374071-46-2

374071-46-2结构式
374071-46-2结构式
  • 常用中文名:CEP-8983
  • 常用英文名:CEP-8983
  • CAS号:374071-46-2
  • 分子式:C18H14N2O3
  • 分子量:306.31500
  • 相关类别: 信号通路 细胞周期/DNA损伤 PARP
  • 发布时间:2016-06-23 01:15:07
  • 更新时间:2024-01-23 18:47:01
  • CEP-8983 是一种 PARP-1 和 PARP-2 抑制剂 (IC50: 20 和 6 nM) 。CEP-8983 是一种有效的化疗增敏剂,可以使化疗耐药细胞系和皮下异种移植物对 Temozolomide (HY-17364) 和 Camptothecin (HY-16560) 敏感。

化源商城直购

英文名 4,5,6,7-tetrahydro-11-methoxy-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)dione
英文别名 7-methoxy-1,2,3,11-tetrahydro-5,11-diaza-benzo[a]trindene-4,6-dione
1H-Cyclopenta(a)pyrrolo(3,4-c)carbazole-1,3(2H)-dione,4,5,6,7-tetrahydro-11-methoxy
描述 CEP-8983 是一种 PARP-1 和 PARP-2 抑制剂 (IC50: 20 和 6 nM) 。CEP-8983 是一种有效的化疗增敏剂,可以使化疗耐药细胞系和皮下异种移植物对 Temozolomide (HY-17364) 和 Camptothecin (HY-16560) 敏感。
相关类别
靶点

20 and 6 nM (PARP-1/2)[1].

参考文献

[1]. Miknyoczki S, et al. The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. Mol Cancer Ther. 2007 Aug;6(8):2290-302.  

分子式 C18H14N2O3
分子量 306.31500
精确质量 306.10000
PSA 74.68000
LogP 2.71240

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ; Location in patent: Page/Page column 19; 24 ;

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

374071-46-2结构式

374071-46-2

文献:CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;